Cart
sales@molnova.com
4-Hydroxyflavanone
CAS No. 6515-37-3
4-Hydroxyflavanone( —— )
Catalog No. M21309 CAS No. 6515-37-3
4-Hydroxyflavanone is a natural product shows full vasorelaxing effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 36 | In Stock |
|
| 25MG | 65 | In Stock |
|
| 50MG | 110 | In Stock |
|
| 100MG | 175 | In Stock |
|
| 200MG | 258 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Hydroxyflavanone
-
NoteResearch use only, not for human use.
-
Brief Description4-Hydroxyflavanone is a natural product shows full vasorelaxing effects.
-
Description4-Hydroxyflavanone is a natural product shows full vasorelaxing effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetNOS
-
Recptornitric oxide
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6515-37-3
-
Formula Weight240.25
-
Molecular FormulaC15H12O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (416.23 mM)
-
SMILESOc1ccc(C(C2)Oc(cccc3)c3C2=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yang C S Huang H C Wang S Y et al. New Diphenol and Isocoumarins from the Aerial Part of Lawsonia inermis and Their Inhibitory Activities against NO Production[J]. Molecules 2016 21(10).
molnova catalog
related products
-
DETA NONOate
DETA NONOate?(NOC 18) is an exogenous nitric oxide (NO) donor with vasodilatory and antidepressant activity.DETA NONOate can be used to activate inward currents in neurons, which may accelerate the healing of MRSA-infected wounds.
-
PTIO
PTIO is a specific scavenger of NO. PTIO reacts with nitric oxide to form nitric dioxide and corresponding imino nitroxides. PTIO can be used to examine nitric oxide synthase inhibitory activity.
-
Epimagnolin B
Epimagnolin B has anti-inflammatory activity, it can inhibit the production of NO and PGE(2) and the expression of respective enzyme iNOS and COX-2 through the suppression of I-kappaB-alpha degradation and nuclear translocation of p65 subunit of NF-kappaB.
